… by the FDA for Phase I studies in humans, works through multiple mechanisms of benefit, including immune modulation … neuroprotection, in pre-clinical models of central nervous system (CNS) injury and disease. Translationally relevant … administration provides documented therapeutic benefit in multiple models of CNS disease and injury, including stroke, …

… (PD). However, achieving reliable, chronic central nervous system (CNS) delivery for macromolecules such as antibodies … peripheral tissue levels will be measured and mapped using multiple technologies. Control experiments will be performed … to the brain of pre-clinical models and achieve levels in multiple brain areas that might be expected to have …

… Octave has developed a precision-care platform for multiple sclerosis that includes a custom biomarker assay … Study Design: Octave has developed a custom assay panel for multiple sclerosis called the MS Disease Activity test. In … signatures with relevant endpoints and employing a systems biology approach to corroborating pathophysiology. …

… in this process cause diseases such as spinal muscular atrophy (SMA), Peutz-Jeghers syndrome, Alzheimer’s disease …

… Systemic administration of erythropoietin (EPO) has been … in animal models of stroke, epilepsy, head injury and multiple sclerosis (MS). It is has been hypothesized that … of the present application is to determine whether systemic administration of EPO reduces dopamine neuron loss …

… corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy and progressive supranuclear palsy. These …